Are noscapine and raloxifene ligands of the bradykinin B


Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 10 05 2022
revised: 15 06 2022
accepted: 16 06 2022
pubmed: 4 7 2022
medline: 18 8 2022
entrez: 3 7 2022
Statut: ppublish

Résumé

The centrally acting antitussive opiate derivative, noscapine, has been claimed to be a non-competitive bradykinin B

Identifiants

pubmed: 35780642
pii: S1567-5769(22)00468-4
doi: 10.1016/j.intimp.2022.108984
pii:
doi:

Substances chimiques

Bradykinin Receptor Antagonists 0
Receptor, Bradykinin B1 0
Receptor, Bradykinin B2 0
Receptors, Bradykinin 0
Raloxifene Hydrochloride 4F86W47BR6
Noscapine 8V32U4AOQU
Bradykinin S8TIM42R2W

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108984

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Hélène Bachelard (H)

Axe Endocrinologie et Néphrologie, Centre de Recherche du CHU de Québec - Université Laval, Québec, QC G1V 4G2, Canada. Electronic address: helene.bachelard@crchudequebec.ulaval.ca.

François Marceau (F)

Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH